Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jun;53(12):1321-1322.
doi: 10.1111/apt.16367.

Editorial: determining disability in IBD - 'See(k) and you shall find'

Jimmy K Limdi  1
Affiliations
Editorial

Editorial: determining disability in IBD - 'See(k) and you shall find'

Jimmy K Limdi. Aliment Pharmacol Ther. 2021 Jun.
No abstract available

PubMed Disclaimer

Comment in

Comment on

  • Determinants of IBD-related disability: a cross-sectional survey from the GETAID.
    Tannoury J, Nachury M, Martins C, Serrero M, Filippi J, Roblin X, Bourrier A, Bouguen G, Franchimont D, Savoye G, Buisson A, Louis E, Nancey S, Abitbol V, Reimund JM, DeWitt O, Vuitton L, Mathieu N, Peyrin-Biroulet L, Gilletta C, Allez M, Viennot S, Trang-Poisson C, Laharie D, Amiot A; GETAID-Patient Experience Study Group. Tannoury J, et al. Aliment Pharmacol Ther. 2021 May;53(10):1098-1107. doi: 10.1111/apt.16353. Epub 2021 Apr 5. Aliment Pharmacol Ther. 2021. PMID: 33817819

References

REFERENCES

    1. Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021. in press.
    1. Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut. 2012;61:241-247.
    1. Le Berre C, Peyrin-Biroulet L; group S-Is. Selecting endpoints for disease-modification trials in inflammatory bowel disease: the SPIRIT consensus from the IOIBD. Gastroenterology. 2021; in press.
    1. Rubin DT, Siegel CA, Kane SV, et al. Impact of ulcerative colitis from patients' and physicians' perspectives: results from the UC: NORMAL survey. Inflamm Bowel Dis. 2009;15:581-588.
    1. Ghosh S, Louis E, Beaugerie L, et al. Development of the IBD disk: a visual self-administered tool for assessing disability in inflammatory bowel diseases. Inflamm Bowel Dis. 2017;23:333-340.

MeSH terms

LinkOut - more resources